BHC
LLY icon

Bowen Hanes & Co’s Eli Lilly LLY Stock Holding History

Bowen Hanes & Co’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$105M Sell
114,646
-648
-0.6% -$657K 2.57% 7
2025
Q4 		$124M Sell
115,294
-2,016
-2% -$1.93M 3.11% 5
2025
Q3 		$89.5M Sell
117,310
-10,930
-9% -$8.13M 2.24% 12
2025
Q2 		$100M Buy
128,240
+185
+0.1% +$144K 2.52% 10
2025
Q1 		$106M Sell
128,055
-495
-0.4% -$412K 2.94% 4
2024
Q4 		$99.2M Buy
128,550
+3,236
+3% +$2.68M 2.66% 7
2024
Q3 		$111M Sell
125,314
-503
-0.4% -$452K 2.91% 4
2024
Q2 		$114M Sell
125,817
-10,683
-8% -$8.55M 3.16% 2
2024
Q1 		$106M Sell
136,500
-4,454
-3% -$3.17M 3.03% 2
2023
Q4 		$82.2M Sell
140,954
-11,701
-8% -$6.83M 2.48% 6
2023
Q3 		$82M Sell
152,655
-7,420
-5% -$3.82M 2.76% 2
2023
Q2 		$75.1M Sell
160,075
-3,640
-2% -$1.53M 2.4% 4
2023
Q1 		$56.2M Sell
163,715
-3,339
-2% -$1.13M 1.93% 19
2022
Q4 		$61.1M Sell
167,054
-3,605
-2% -$1.28M 2.17% 11
2022
Q3 		$55.2M Buy
170,659
+1,560
+0.9% +$494K 2.13% 12
2022
Q2 		$54.8M Sell
169,099
-746
-0.4% -$224K 1.99% 15
2022
Q1 		$48.6M Buy
169,845
+11,120
+7% +$2.86M 1.45% 29
2021
Q4 		$43.8M Buy
+158,725
New +$40.2M 1.24% 34
2019
Q1 		– Sell
-15,000
Closed -$1.74M – 165
2018
Q4 		$1.74M Buy
+15,000
New +$1.68M 0.09% 88

Other funds holding LLY

Lilly Endowment
Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Bowen Hanes & Co's LLY Position: Q1 2026 in Review

Bowen Hanes & Co reduced its Eli Lilly (LLY) stake by 0.56% in Q1 2026, selling an estimated $657K and leaving 114,646 shares worth $105M. The position accounts for 2.57% of the portfolio, ranked #7.

Bowen Hanes & Co first reported a position in LLY in Q4 2018 and has held it in 19 quarters since. The position peaked at $124M in Q4 2025. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Bowen Hanes & Co held 114,646 shares of Eli Lilly worth $105M as of Q1 2026.
  • Bowen Hanes & Co sold 648 Eli Lilly shares in Q1 2026, an estimated $657K.
  • Eli Lilly made up 2.57% of Bowen Hanes & Co's portfolio in Q1 2026, its #7 holding.
  • Bowen Hanes & Co first reported a position in Eli Lilly in Q4 2018 and has held it in 19 quarters since.
  • Bowen Hanes & Co's Eli Lilly position peaked at $124M in Q4 2025.
  • 4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Bowen Hanes & Co's 13F filing for Q1 2026, filed 14 May 2026.